Tyrosine kinases (TKs) belong to a relatively complex class of enzymes that emerged at an early stage of evolution, and are involved in phosphorylation and dephosphorylation of proteins together with protein phosphatases. TKs are key molecules in signaling pathways and important targets in drug discovery. There are two types of tyrosine kinases in cells: receptor tyrosine kinases and non-receptor tyrosine kinases. The main roles of TKs include regulation of multicellular functions of the body. Intercellular signals related to growth, differentiation, adhesion, motility, and death are usually transmitted via tyrosine kinases. Tyrosine kinases are attractive biological targets for cancer therapy because their abnormal signaling is often associated with tumor development and growth.
BOC Sciences can design a new tyrosine kinase screening library containing approximately 5,700 drug-like screening compounds for high-throughput screening (HTS).
At BOC Sciences, the generated potential tyrosine kinase inhibitors possess activity against the following targets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Figure 1. A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors. (Lotz-Jenne, C.; et al. 2016)
BOC Sciences provides professional, rapid and high-quality services of Tyrosine Kinase Screening Library design at competitive prices for global customers. Personalized and customized services of Tyrosine Kinase Screening Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.